Apixaban 2.5 mg
Apixaban 5 mg
Clotexia is a direct, selective factor Xa inhibitor, used for: Prevention of stroke in patients with atrial fibrillation. Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE). Prevention of venous thromboembolism (VTE) following knee or hip replacement.
Clotexia tablet:
- Rapid onset of action.
- Predictable anticoagulant effect.
- Low potential for food and drug interactions.
- Laboratory monitoring is not required. Simple, effective, and safe dosage regimen for the initial and long-term use.
- Low risk of major bleeding (including GI bleeding) in all age groups.
- Safer than other oral anticoagulant agents in patients with renal insufficiency.
- Suitable for atrial fibrilation patients who are not candidates for vitamin K antagonist therapy.